Reports for MabQuest Therapeutics SA
Credit rating information
Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.Find out more
Economic information
Comprehensive information about the economic situation of a company.Find out more
Payment collection information
Overview of current and past debt enforcement proceedings.Find out more
Company dossier as PDF
Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.Retrieve company dossier
About MabQuest Therapeutics SA
- MabQuest Therapeutics SA has its legal headquarters in Lausanne, is active and operates in the sector «Research and development».
- MabQuest Therapeutics SA was founded on 10.06.2015.
- The company has last modified its commercial register entry on 19.08.2025. All previous commercial register entries are available under «Notifications».
- The reported UID is the following: CHE-165.629.764.
- ADAE SA, Sivry-Rance, succursale de Lausanne, Ayora SA, Bakir In & Out are registered at the same address.
Commercial register information
Entry in the commercial register
10.06.2015
Legal form
Company limited by shares (AG)
Legal headquarters of the company
Pully
Commercial Registry Office
VD
Commercial register number
CH-550.1.161.568-0
UID/VAT
CHE-165.629.764
Sector
Research and development
Purpose (Original language)
La société a pour but de développer des agents thérapeutiques (pour but complet cf. statuts).
Other company names
Past and translated company names
- MabQuest SA
Branches (0)
Ownership structure
Holdings
Newest SOGC notifications: MabQuest Therapeutics SA
The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications
Publication number: HR02-1006412051, Commercial Registry Office Vaud, (550)
MabQuest SA, à Pully, CHE-165.629.764 (FOSC du 09.06.2023, p. 0/1005765489). Statuts modifiés le 06.08.2025.
Nouvelle raison de commerce:
MabQuest Therapeutics SA. Augmentation ordinaire du capital-actions.
Nouveau capital-actions entièrement libéré:
CHF 157'000, divisé en 157'000 actions nominatives de CHF 1, avec restrictions quant à la transmissibilité selon statuts.
Hit list
Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.